Clinical stage biotechnology firm Pharmacyte Biotech Inc (OTCMKTS:PMCB) announced on Thursday that David A. Judd is the latest executive to join its Medical and Scientific Advisory board. The company believes that Judd is a great addition...

Mr. David Judd, a consultant cellular biologist, and Chief Executive Officer of Pharmacyte Biotech Inc (OTCMKTS:PMCB), Kenneth L. Waggoner will visit the GMP production facility of Austrianova in Bangkok, Thailand. They will oversee the production...

Pharmacyte Biotech Inc (OTCMKTS:PMCB) currently working on its Investigational New Drug application and has sought the expertise of cGMP Validation to ensure that they submit a flawless masterpiece to the U.S Food and Drug Administration (FDA)...

Pharmacyte Biotech Inc (OTCMKTS:PMCB) announced that Eurofins Lancaster Laboratories, a major Contract Manufacturing Organization that company selected to set its Master Cell Bank, has successfully concluded its independent growth assessment...

Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that its senior management will attend the annual meeting of the ASCO. The theme of this meeting is focused on bringing a difference in cancer care. Kenneth L. Waggoner, the CEO, reported that this...

Pharmacyte Biotech Inc (OTCMKTS:PMCB), one of the top clinical stage biotechnology companies that has done much towards developing targeted treatments for diabetes and cancer has been hitting headlines lately for the positive steps it has been...